Robotic-assisted versus laparoscopic left pancreatectomy at a high-volume, minimally invasive center

Surg Endosc. 2019 Sep;33(9):2991-3000. doi: 10.1007/s00464-018-6565-6. Epub 2018 Nov 12.

Abstract

Introduction: While minimally invasive left pancreatectomy has become more widespread and generally accepted over the last decade, opinions on modality of minimally invasive approach (robotic or laparoscopic) remain mixed with few institutions performing a significant portion of both operative approaches simultaneously.

Methods: 247 minimally invasive left pancreatectomies were retrospectively identified in a prospectively maintained institutional REDCap™ database, 135 laparoscopic left pancreatectomy (LLP) and 108 robotic-assisted left pancreatectomy (RLP). Demographics, intraoperative variables, postoperative outcomes, and OR costs were compared between LLP and RLP with an additional subgroup analysis for procedures performed specifically for pancreatic adenocarcinoma (35 LLP and 23 RLP) focusing on pathologic outcomes and 2-year actuarial survival.

Results: There were no significant differences in preoperative demographics or indications between LLP and RLP with 34% performed for chronic pancreatitis and 23% performed for pancreatic adenocarcinoma. While laparoscopic cases were faster (p < 0.001) robotic cases had a higher rate of splenic preservation (p < 0.001). Median length of stay was 5 days for RLP and LLP, and rate of clinically significant grade B/C pancreatic fistula was approximately 20% for both groups. Conversion rates to laparotomy were 4.3% and 1.8% for LLP and RLP approaches respectively. RLP had a higher rate of readmission (p = 0.035). Pathologic outcomes and 2-year actuarial survival were similar between LLP and RLP. LLP on average saved $206.67 in OR costs over RLP.

Conclusions: This study demonstrates that at a high-volume center with significant minimally invasive experience, both LLP and RLP can be equally effective when used at the discretion of the operating surgeon. We view the laparoscopic and robotic platforms as tools for the modern surgeon, and at our institution, given the technical success of both operative approaches, we will continue to encourage our surgeons to approach a difficult operation with their tool of choice.

Keywords: Distal pancreatectomy; Laparoscopic pancreatectomy; Left pancreatectomy; Minimally invasive pancreatectomy; Robotic pancreatectomy; Robotic-assisted pancreatectomy.

Publication types

  • Comparative Study

MeSH terms

  • Cytoreduction Surgical Procedures* / adverse effects
  • Cytoreduction Surgical Procedures* / instrumentation
  • Cytoreduction Surgical Procedures* / methods
  • Female
  • Hospitals, High-Volume / statistics & numerical data
  • Humans
  • Laparoscopy* / adverse effects
  • Laparoscopy* / methods
  • Length of Stay
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care
  • Pancreatectomy* / adverse effects
  • Pancreatectomy* / instrumentation
  • Pancreatectomy* / methods
  • Pancreatic Neoplasms* / pathology
  • Pancreatic Neoplasms* / surgery
  • Pancreatitis, Chronic / surgery*
  • Retrospective Studies
  • Robotic Surgical Procedures* / adverse effects
  • Robotic Surgical Procedures* / methods